Intratumoral heterogeneity in primary breast carcinoma: Study of concurrent parameters

Journal of Surgical Oncology

Volumn 64, Issue 4, 1997, Pages 280-288

  Dodd, Leslie G ^a,b   Kerns, B J ^a   Dodge, Richard K ^b   Layfield, Lester J ^a  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

breast carcinoma; DNA ploidy; proliferation; tumor heterogeneity

Indexed keywords

DNA;

ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; CLINICAL ARTICLE; DNA CONTENT; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIVISION; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; PLOIDIES; PROGNOSIS;

EID: 0030888395     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199704)64:4<280::AID-JSO6>3.0.CO;2-5     Document Type: Article

References (50)

1. Kallioniemi OP: Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumoral heterogeneity. Cytometry 1988;9:164-169.
2. Erhardt K, Auer G: Mammary carcinoma: DNA analysis in areas showing different histological features in the same tumor. Acta Pathol Microbiol Immunol Scand A 1986;94:21-28.
3. Bonsing BA, Beerman H, Kuipers-Dijkshoorn N, et al.: High levels of DNA index heterogeneity in advanced breast carcinoma. Cancer 1993;71:382-391.
4. Prey MU, Meyer JS, Stone KR, McDivitt RW: Heterogeneity of breast carcinomas determined by flow cytometric analysis. J Surg Oncol 1985;29:35-39.
5. Fuhr JE, Frye A, Kattine AA, Van Meterer S: Flow cytometric determination of breast tumor heterogeneity. Cancer 1991;67:1401-1405.
6. Meyer JS, Wittliff JL: Regional heterogeneity in breast carcinoma: thymidine labeling index, steroid hormone receptors, DNA ploidy. Int J Cancer 1991;47:213-220.
7. Beerman H, Smit VT, Kluin PM, Bonsing BA, et al.: Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer. Cytometry 1991;12:147-154.
8. Symmans WF, Liu J, Knowles DM, Inghirami G: Breast cancer heterogeniety: Evaluation of clonality in primary and metastatic lesions. Hum Pathol 1995;26:210-216.
9. Poulson HS, Jensen J, Hermansen C: Human breast cancer: Heterogeneity of estrogen binding sites. Cancer 1981;48:1791-1793.
10. Castagnetta L, Traina A, DiCarlo A, et al.: Do multiple oestrogen receptor assays give significant additional information for the management of breast cancer. Br J Cancer 1989;59:636-638.
11. Siitonen S, Isola JJ, Rantala IS, Helin HJ: Intratumor variation in cell proliferation in breast carcinoma as determined by antiproliferating cell nuclear antigen monoclonal antibody and automated image analysis. Am J Clin Pathol 1993;9:226-231.
12. Auer GU, Caspersson TO, Wallgren AS: DNA content and survival in mammary carcinoma. Anal Quant Cytol 1980;2:161-165.
13. Coulson PB, Thornwaite JT, Woolley TW, et al.: Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer survival. Cancer Res 1984;44:4187-4196.
14. Auer G, Eriksson E, Azavedo E, et al.: Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Res 1984;44:394-396.
15. McGuire WL, Dressler LG: Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. J Natl Cancer Inst 1985;75:405-410.
16. Thorud E, Fossa SD, Vaage S, Kaalhus O, et al.: Primary breast cancer: Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics. Cancer 1986;57:808-811.
17. Kallioniemi O-P, Banco G, Alavaikko M, et al.: Tumor DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer 1987;56:637-642.
18. Fallenius AG, Auer GU, Carstensen JM: Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer 1988;62:331-341.
19. Beerman H, Kluin PM, Van de Velde CJH, Cornelisse CJ: Prognostic significance of DNA ploidy in a series of 690 breast cancer patients. Int J Cancer 1990;45:34-39.
20. Clark GM, Dressler LG, Owens MA, et al.: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 1989;320:627-633.
21. Cornelisse CJ, van de Velde CJH, Caspers RJC, et al.: DNA ploidy and survival in breast cancer patients. Cytometry 1987;8:225-234.
22. Del Bino G, Silvestrini R, Zucconi MR, et al.: DNA ploidy of human breast cancer. Anal Cell Pathol 1989;1:215-223.
23. Dressler LG, Seamer LC, Owens MA, et al.: DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988;61:420-427.
24. Hedley DW, Rugg CA, Gelber RD: Association of DNA index and s-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res 1987;47:4729-4735.
25. Jakobsen A, Poulsom HS, Madsen EL, et al.: Ploidy level of human breast carcinoma: Relation to histopathologic features and hormone receptor content. Acta Radiol Oncol 1984;23:103-107.
26. Raber MN, Barlogie B, Latreille J, et al.: Ploidy, proliferative activity and estrogen receptor content in human breast cancer. Cytometry 1982;3:36-42.
27. Frierson HF: Grade and flow cytometric analysis of ploidy for infiltrating ductal carcinomas. Hum Pathol 1993;24:24-29.
28. Bauer TW, Tubbs RR, Edinger MG, Suit PF, et al.: A prospective comparison of DNA quantitation by image and flow cytometry. Am J Clin Pathol 1990;93:322-326.
29. Clemo FA, Crabtree WN, Walker E, DeNicola DB: Comparison of image analysis and flow cytometric measurements of DNA content of canine transitional cell carcinomas. Anal Quant Cytol 1993;15:418-426.
30. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 1957;11:359-377.
31. Bacus JW, Bacus JV: A method of correcting DNA ploidy measurements in tissue sections. Mod Pathol 1994;7:652-664.
32. Sapi Z, Hendricks JB, Pharis PG, Wilkinson EJ: Tissue section image analysis of breast neoplasms. Evidence of false aneuploidy. Am J Clin Pathol 1993;99:714-720.
33. Snedecor GW, Cochran WG: "Statistical Methods" 7th Ed. Ames, IA: Iowa State University Press, 1980, p192.
34. Armitage P: "Statistical Methods in Medical Research." New York: Blackwell Scientific, 1971, p127.
35. Harris JR, Hellsman S, Canellos GP, Fisher B: Cancer of the breast. In DeVita VT, Hellsman S, Rosenberg SA (eds): "Cancer Principles and Practice of Oncology." 4th Ed. Philadelphia: JB Lippincott, 1993, p1310-1311.
36. Whitliff JL: Steroid hormone receptors in breast cancer. Cancer 1984;53:630-643.
37. Collan Y, Klemi P, Kallioniemi OP, et al.: Significance of variation in DNA flow cytometric analysis from paraffin embedded breast cancers. Pathol Res Pract 1992;188:581-586.
38. Kallioniemi OP, Joensuu H, Klemi P, Koivula T: Inter-laboratory comparison of DNA flow cytometric results from paraffin-embedded breast carcinoma. Breast Cancer Res Treat 1990;17:59-61.
39. Askensten UG, van Rosen AK, Nilsson RS, Auer GU: Intratumoral variations in DNA distribution patterns in mammary adenocarcinomas. Cytometry 1989;10:326-333.
40. Ferno M, Baldetorp B, Ewers SB, et al.: One or more samplings for flow cytometric DNA analysis in breast cancer - Prognostic implications? Cytometry 1992;13:241-249.
41. Schutte B, Reynders MMJ, Bosman FT, Blijham GH: Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 1985;6:26-30.
42. Feichter GE, Goerttler K: Pitfalls in the preparation of nuclear suspensions from paraffin embedded tissue for flow cytometry. Cytometry 1986;7:616.
43. Stephenson RA, Gay H, Fair WR, Melamed MR: Effect of section thickness on quality of flow cytometric DNA content determinations in paraffin-embedded tissues. Cytometry 1986;7:41-44.
44. Frierson HF: Flow cytometric analysis of ploidy in solid neoplasms. Comparison of fresh tissues with formalin fixed paraffin-embedded specimens. Hum Pathol 1988;19:290-294.
45. Yung WK, Shapiro JR, Shapiro WR: Heterogeneous chemosensitivities of subpopulutions of human glioma cells in culture. Cancer Res 1982;42:992-998.
46. Leith JT, Dexter DL, DeWyngaert JK, et al.: Differential responses to x-irradiation of subpopulations of two heterogeneous human carcinomas in vitro. Cancer Res 1982;42:2556-2561.
47. Manni A, Lancaster S, English H, et al.: Kinetic and morphometric responses of heterogeneous populations of NMU-induced rat mammary tumor cells to hormone and antipolyamine therapy in vivo. Breast Cancer Res Treat 1991;17:179-186.
48. Wersto RP, Liblit RL, Deitch D, Koss LG: Variability in DNA measurements in multiple tumor samples of human colonic carcinoma. Cancer 1991;67:106-115.
49. Dangou J-M, Kiss R, DePrez C, et al.: Heterogeneity of DNA ploidy, proliferation indices and nuclear size in human colorectal carcinomas. Anal Quant Cytol Histol 1993;15:23-31.
50. Stipa S, Danesi DT, Modini C, et al.: The importance of heterogeneity and of multiple site sampling in prospective determination of deoxyribonucleic acid flow cytometry. Surg Gynecol Obstet 1993;176:427-434.